Eli Lilly's most recent trend suggests a bearish bias. One trading opportunity on Eli Lilly is a Bear Call Spread using a strike $73.00 short call and a strike $78.00 long call offers a potential 21.36% return on risk over the next 11 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $73.00 by expiration. The full premium credit of $0.88 would be kept by the premium seller. The risk of $4.12 would be incurred if the stock rose above the $78.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Eli Lilly is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Eli Lilly is bearish.
The RSI indicator is below 20 which suggests that the stock is in oversold territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Eli Lilly
Bernie Sanders Seeks DOJ Drug Probe (LLY, SNY)
Sat, 05 Nov 2016 15:01:00 GMT
What Do Analysts Recommend for Novo?
Fri, 04 Nov 2016 12:04:11 GMT
Seattle research institute awarded $15M for tuberculosis drug development
Thu, 03 Nov 2016 21:25:12 GMT
Lilly Presents Clinical Efficacy, Safety and Patient-Reported Outcomes Data of Baricitinib in Patients with Rheumatoid Arthritis at 2016 American College of Rheumatology Annual Meeting
Thu, 03 Nov 2016 17:16:00 GMT
PR Newswire – INDIANAPOLIS, Nov. 3, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced that new post-hoc analyses of pooled efficacy and safety data from baricitinib phase 3 studies, along with findings …
LILLY ELI & CO Financials
Thu, 03 Nov 2016 17:04:09 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook